Genetic testing revealed a pathogenic <i>CHEK2</i> nonsense variant (p.Trp411*), a likely pathogenic <i>MSH6</i> frameshift variant, and a breast cancer PRS in the 99th percentile. This evidence concerns the gene MSH6 and breast carcinoma.